Evidence map›Paper›PMID 27529332›Full record

ArticleAngewandte Chemie (International ed. in English)2016

Cell-Permeable Peptides Containing Cycloalanine Residues.

Hao Wu, Guillaume Mousseau, Sonia Mediouni, Susana T Valente, Thomas Kodadek

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Late-Stage Functionalization of Peptides on the Solid Phase.Angewandte Chemie (International ed. in English) · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Emerging Methods and Design Principles for Cell-Penetrant Peptides.Angewandte Chemie (International ed. in English) · 2018
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Hao WuDepartment of Chemistry and Cancer Biology, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL, 33458, USA.ORCID 0000-0001-9487-5331
Guillaume MousseauDepartment of Immunology and Microbial Sciences, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL, 33458, USA.
Sonia MediouniDepartment of Immunology and Microbial Sciences, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL, 33458, USA.
Susana T ValenteDepartment of Immunology and Microbial Sciences, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL, 33458, USA.
Thomas KodadekDepartment of Chemistry and Cancer Biology, The Scripps Research Institute, 130 Scripps Way, Jupiter, FL, 33458, USA. kodadek@scripps.edu.ORCID 0000-0003-1930-4795

Funding

Discovery of antibody biomarkers for Alzheimer’s DiseaseR21AG052813 · NIA · SCRIPPS FLORIDA · PI KODADEK, THOMAS J. · 2016 to 2017
$528k
NIA NIH HHS R21 AG052813
6 · The paper itself

Abstract

We present here an efficient alternative to N-methylation for the purpose of morphing protein-binding peptides into more serum-stable and cell-permeable compounds. This involves the incorporation of a cycloalanine (CyAla) into a peptide in a way that avoids difficult coupling steps. We demonstrate the utility of this chemistry in creating a cell-permeable derivative of a high-affinity HIV Rev protein-binding peptide.

Indexed as

AlanineCell-Penetrating PeptidesHeLa CellsHumansMolecular ConformationAlanineCell-Penetrating Peptidesantiviralcell permeabilitycyclic peptidesHIV Revpeptidomimetics

Identifiers

PMID27529332
PMCPMC5220248

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.